← Evidence map

ArticleJournal of clinical tuberculosis and other mycobacterial diseases2021

Should treatment of low-level rifampicin mono-resistant tuberculosis be different?

F A Gopie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33598570